trial

Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications

NCTId NCT01409590
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 100 (actual)
Sponsored by Sheba Medical Center
Primary completion 2006-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
100 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2005-05
Primary completion
2006-09
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
Exercise programDiet

Sponsors

Sheba Medical CenterLead Sponsor

Investigators

1
Revital Amiaz, MDPrincipal Investigator

Sites

1 total
Tel Litwinsky, Israel

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2006-09
Status
COMPLETED
relationships
The graph out of here
drug
Exercise program
drug
Diet
drug
lead_sponsor
Sheba Medical Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
Weight Gain
indication
investigator
Revital Amiaz, MD
person